Case Report

Year : 2023 | Volume : 7 | Issue : 2 | Page : 33-36

Drug-Induced Gingival Enlargement: Non-Surgical Management

Pradnya Dattatraya Kadam, BDS, MDS. 1* | Mala Dixit Baburaj, BDS, MDS2* | Bhalchandra Thorat, BDS, MDS 3*

1Department of Dentistry, Shree Bhausaheb Hire Govt Medical College, Dhule-424002, Maharashtra, India 2Department of Periodontology and Implantology, Nair Hospital Dental College, Mumbai-400008, Maharashtra, India 3Department of Dentistry, St.George Govt.Dental College, Mumbai, Mumbai-400001, Maharashtra, India

Correspondence

Dr. Pradnya Dattatraya Kadam, Department of Dentistry, Shree Bhausaheb Hire Govt Medical College, Dhule-424002, Maharashtra, India

Email: pradnyakadam024@gmail.com

Abstract

Gingival overgrowth was a side effect of several different drug classes, including anticonvulsants, immunosuppressants, and calcium channel blockers. Extracellular collagenous matrix components accumulate together with varying degrees of inflammation to describe it. The anti-epileptic phenytoin is one of the main medications linked to gingival overgrowth. It affects gingival tissues by changing the metabolism of the extracellular matrix. This paper aims to present a case report on non-surgical management of phenytoin drug induced gingival enlargement.

K E Y W O R D S Phenytoin; Gingival Overgrowth; Antiepileptic Drug; Epilepsy; Case report

Conflict of interest

The authors have no conflicts of interest to declare.

Funding information

Nil

How to cite this article: Dattatraya Kadam P, Baburaj MD, Thorat B. Drug Induced Gingival Enlargement: Non-Surgical Management. Int J Orofac Res [Internet]. 2023 Nov. 5 [cited 2023 Nov. 6];7(2):33-6. Available from: https://www.editorialmanager.in/index.php/ijofr/article/view/887